{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:03:38Z","timestamp":1778519018540,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s11912-025-01637-7","type":"journal-article","created":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T12:37:29Z","timestamp":1737463049000},"page":"148-156","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Advances in Radiation Oncology in Soft Tissue Sarcoma"],"prefix":"10.1007","volume":"27","author":[{"given":"Sara B.","family":"Leier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safia K.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,21]]},"reference":[{"key":"1637_CR1","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0360-3016(93)90236-O","volume":"27","author":"LB Harrison","year":"1993","unstructured":"Harrison LB, Franzese F, Gaynor JJ, et al. Long-term results of a prospective randomized trial of adjuvant brachytherapy in the management of completely resected soft tissue sarcomas of the extremity and superficial trunk. Int J Radiat Oncol Biol Phys. 1993;27:259\u201365.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1637_CR2","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/00000658-198209000-00009","volume":"196","author":"SA Rosenberg","year":"1982","unstructured":"Rosenberg SA, Tepper J, Glatstein E, et al. The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg. 1982;196:305\u201315.","journal-title":"Ann Surg"},{"key":"1637_CR3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1200\/JCO.1998.16.1.197","volume":"16","author":"JC Yang","year":"1998","unstructured":"Yang JC, Chang AE, Baker AR, et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol. 1998;16:197\u2013203.","journal-title":"J Clin Oncol"},{"key":"1637_CR4","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1002\/cncr.26415","volume":"118","author":"RF Riedel","year":"2012","unstructured":"Riedel RF. Systemic therapy for advanced soft tissue sarcomas: highlighting novel therapies and treatment approaches. Cancer. 2012;118:1474\u201385.","journal-title":"Cancer"},{"key":"1637_CR5","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s11864-012-0196-2","volume":"13","author":"WT van der Graaf","year":"2012","unstructured":"van der Graaf WT, Gelderblom H. New systemic therapy options for advanced sarcomas. Curr Treat Options Oncol. 2012;13:306\u201317.","journal-title":"Curr Treat Options Oncol"},{"key":"1637_CR6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.radonc.2004.12.020","volume":"75","author":"AM Davis","year":"2005","unstructured":"Davis AM, O\u2019Sullivan B, Turcotte R, et al. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol. 2005;75:48\u201353.","journal-title":"Radiother Oncol"},{"key":"1637_CR7","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1016\/S0140-6736(02)09292-9","volume":"359","author":"B O\u2019Sullivan","year":"2002","unstructured":"O\u2019Sullivan B, Davis AM, Turcotte R, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet. 2002;359:2235\u201341.","journal-title":"Lancet"},{"key":"1637_CR8","doi-asserted-by":"publisher","unstructured":"Kose\u0142a-Paterczyk H, Szacht M, Morysi\u0144ski T, \u0142ugowska I, Dziewirski W, Falkowski S, Zdzienicki M, Pie\u0144kowski A, Szamotulska K, Switaj T, Rutkowski P. Preoperative hypofractionated radiotherapy inthe treatment of localized soft tissue sarcomas. Eur J Surg Oncol. 2014;40(12):1641\u20137. https:\/\/doi.org\/10.1016\/j.ejso.2014.05.016","DOI":"10.1016\/j.ejso.2014.05.016"},{"key":"1637_CR9","doi-asserted-by":"crossref","unstructured":"Pennington JD, Eilber FC, Eilber FR, Singh AS, Reed JP, Chmielowski B, et al. Long-term Outcomes With Ifosfamide-based Hypofractionated Preoperative Chemoradiotherapy for Extremity Soft Tissue Sarcomas. Am J Clin Oncol. 2018;41(12):1154\u20131161.","DOI":"10.1097\/COC.0000000000000443"},{"key":"1637_CR10","doi-asserted-by":"crossref","unstructured":"Kalbasi A, Kamrava M, Chu FI, Telesca D, Van Dams R, Yang Y, et al. A Phase II Trial of 5-Day Neoadjuvant Radiotherapy for Patients with High-Risk Primary Soft Tissue Sarcoma. Clin Cancer Res. 2020;26(8):1829\u20131836","DOI":"10.1158\/1078-0432.CCR-19-3524"},{"key":"1637_CR11","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.adro.2020.06.024","volume":"5","author":"S Parsai","year":"2020","unstructured":"Parsai S, Lawrenz J, Kilpatrick S, et al. Early outcomes of Preoperative 5-Fraction Radiation Therapy for Soft tissue sarcoma followed by Immediate Surgical Resection. Adv Radiat Oncol. 2020;5:1274\u20139.","journal-title":"Adv Radiat Oncol"},{"key":"1637_CR12","doi-asserted-by":"publisher","first-page":"100850","DOI":"10.1016\/j.adro.2021.100850","volume":"7","author":"M Bedi","year":"2022","unstructured":"Bedi M, Singh R, Charlson JA, et al. Is 5 the New 25? Long-term oncologic outcomes from a phase II, prospective, 5-Fraction Preoperative Radiation Therapy Trial in patients with localized soft tissue sarcoma. Adv Radiat Oncol. 2022;7:100850.","journal-title":"Adv Radiat Oncol"},{"key":"1637_CR13","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/S1470-2045(22)00638-6","volume":"23","author":"BA Guadagnolo","year":"2022","unstructured":"Guadagnolo BA, Bassett RL, Mitra D, et al. Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial. Lancet Oncol. 2022;23:1547\u201357.","journal-title":"Lancet Oncol"},{"key":"1637_CR14","doi-asserted-by":"publisher","first-page":"101401","DOI":"10.1016\/j.adro.2023.101401","volume":"9","author":"SK Ahmed","year":"2024","unstructured":"Ahmed SK, Petersen IA, Grams MP, et al. Spatially fractionated Radiation Therapy in Sarcomas: a large single-Institution experience. Adv Radiat Oncol. 2024;9:101401.","journal-title":"Adv Radiat Oncol"},{"key":"1637_CR15","doi-asserted-by":"crossref","unstructured":"Bishop AJ, Mitra D, Farooqi A et al. Moderately hypofractionated, preoperative radiotherapy in patients with soft tissue sarcomas (HYPORT-STS): updated local control, late toxicities, and patient-reported outcomes. Cancer. 2025;131(1):e35542","DOI":"10.1002\/cncr.35542"},{"key":"1637_CR16","doi-asserted-by":"publisher","first-page":"101391","DOI":"10.1016\/j.adro.2023.101391","volume":"9","author":"M Mills","year":"2024","unstructured":"Mills M, Miller J, Liveringhouse C, et al. Novel postoperative Hypofractionated Accelerated Radiation Dose-Painting Approach for Soft tissue sarcoma. Adv Radiat Oncol. 2024;9:101391.","journal-title":"Adv Radiat Oncol"},{"key":"1637_CR17","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.ijrobp.2004.03.009","volume":"60","author":"G Pitson","year":"2004","unstructured":"Pitson G, Robinson P, Wilke D, et al. Radiation response: an additional unique signature of myxoid liposarcoma. Int J Radiat Oncol Biol Phys. 2004;60:522\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1637_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s13566-012-0085-0","volume":"2","author":"A Betgen","year":"2013","unstructured":"Betgen A, Haas RL, Sonke JJ. Volume changes in soft tissue sarcomas during preoperative radiotherapy of extremities evaluated using cone-beam CT. J Radiat Oncol. 2013;2:55\u201362.","journal-title":"J Radiat Oncol"},{"key":"1637_CR19","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.ijrobp.2008.03.008","volume":"72","author":"RS de Vreeze","year":"2008","unstructured":"de Vreeze RS, de Jong D, Haas RL, et al. Effectiveness of radiotherapy in myxoid sarcomas is associated with a dense vascular pattern. Int J Radiat Oncol Biol Phys. 2008;72:1480\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1637_CR20","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1245\/s10434-011-2127-z","volume":"19","author":"LC Moreau","year":"2012","unstructured":"Moreau LC, Turcotte R, Ferguson P, et al. Myxoid\\round cell liposarcoma (MRCLS) revisited: an analysis of 418 primarily managed cases. Ann Surg Oncol. 2012;19:1081\u20138.","journal-title":"Ann Surg Oncol"},{"key":"1637_CR21","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.ijrobp.2007.07.2337","volume":"70","author":"BA Guadagnolo","year":"2008","unstructured":"Guadagnolo BA, Zagars GK, Ballo MT, et al. Excellent local control rates and distinctive patterns of failure in myxoid liposarcoma treated with conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2008;70:760\u20135.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1637_CR22","doi-asserted-by":"publisher","first-page":"e205865","DOI":"10.1001\/jamaoncol.2020.5865","volume":"7","author":"J Lansu","year":"2021","unstructured":"Lansu J, Bovee J, Braam P, et al. Dose reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: a Nonrandomized Controlled Trial. JAMA Oncol. 2021;7:e205865.","journal-title":"JAMA Oncol"},{"key":"1637_CR23","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.ijrobp.2005.03.004","volume":"63","author":"L Kepka","year":"2005","unstructured":"Kepka L, DeLaney TF, Suit HD, et al. Results of radiation therapy for unresected soft-tissue sarcomas. Int J Radiat Oncol Biol Phys. 2005;63:852\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1637_CR24","doi-asserted-by":"publisher","first-page":"101447","DOI":"10.1016\/j.adro.2024.101447","volume":"9","author":"JM Bryant","year":"2024","unstructured":"Bryant JM, Mills MN, Yang GQ, et al. Novel definitive Hypofractionated Accelerated Radiation dose-painting (HARD) for Unresected Soft tissue sarcomas. Adv Radiat Oncol. 2024;9:101447.","journal-title":"Adv Radiat Oncol"},{"key":"1637_CR25","doi-asserted-by":"publisher","first-page":"100913","DOI":"10.1016\/j.adro.2022.100913","volume":"7","author":"D Boyce-Fappiano","year":"2022","unstructured":"Boyce-Fappiano D, Damron EP, Farooqi A, et al. Hypofractionated Radiation Therapy for Unresectable or metastatic sarcoma lesions. Adv Radiat Oncol. 2022;7:100913.","journal-title":"Adv Radiat Oncol"},{"key":"1637_CR26","doi-asserted-by":"crossref","unstructured":"Bryant JM, Mills MN, Liveringhouse C et al. Hypofractionated accelerated radiation dose-painting (HARD) improves outcomes in unresected soft-tissue sarcoma. Radiother Oncol. 2024;5(202):110644.","DOI":"10.1016\/j.radonc.2024.110644"},{"key":"1637_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s13566-012-0064-5","volume":"2","author":"A Kaiser","year":"2013","unstructured":"Kaiser A, Mohiuddin M, Jackson G. Dramatic response from neoadjuvant, spatially fractionated GRID radiotherapy (SFGRT) for large, high-grade extremity sarcoma. J Radiation Oncol. 2013;2:103\u20136.","journal-title":"J Radiation Oncol"},{"key":"1637_CR28","doi-asserted-by":"crossref","unstructured":"Kudrimoti M, Mohiuddin M, Ahmed MM et al. Use of high dose spatially fractionated radiation (GRID therapy) in management of large, poor prognostic stage III (>\u200910cms) soft tissue sarcomas. Int J Radiat Oncol Biol Phys 60, 2004.","DOI":"10.1016\/S0360-3016(04)01868-1"},{"key":"1637_CR29","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1667\/RADE-20-00100.1","volume":"194","author":"JW Snider","year":"2020","unstructured":"Snider JW, Molitoris J, Shyu S, et al. Spatially fractionated Radiotherapy (GRID) prior to Standard Neoadjuvant conventionally fractionated Radiotherapy for Bulky, High-Risk Soft tissue and Osteosarcomas: feasibility, Safety, and Promising Pathologic Response Rates. Radiat Res. 2020;194:707\u201314.","journal-title":"Radiat Res"},{"key":"1637_CR30","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1177\/153303460600500608","volume":"5","author":"JL Huhn","year":"2006","unstructured":"Huhn JL, Regine WF, Valentino JP, et al. Spatially fractionated GRID radiation treatment of advanced neck disease associated with head and neck cancer. Technol Cancer Res Treat. 2006;5:607\u201312.","journal-title":"Technol Cancer Res Treat"},{"key":"1637_CR31","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.ijrobp.2009.03.030","volume":"76","author":"JA Penagaricano","year":"2010","unstructured":"Penagaricano JA, Moros EG, Ratanatharathorn V, et al. Evaluation of spatially fractionated radiotherapy (GRID) and definitive chemoradiotherapy with curative intent for locally advanced squamous cell carcinoma of the head and neck: initial response rates and toxicity. Int J Radiat Oncol Biol Phys. 2010;76:1369\u201375.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1637_CR32","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1177\/153303460200100207","volume":"1","author":"S Sathishkumar","year":"2002","unstructured":"Sathishkumar S, Dey S, Meigooni AS, et al. The impact of TNF-alpha induction on therapeutic efficacy following high dose spatially fractionated (GRID) radiation. Technol Cancer Res Treat. 2002;1:141\u20137.","journal-title":"Technol Cancer Res Treat"},{"key":"1637_CR33","first-page":"30","volume":"20","author":"W Yan","year":"2020","unstructured":"Yan W, Khan MK, Wu X, et al. Spatially fractionated radiation therapy: history, present and the future. Clin Transl Radiat Oncol. 2020;20:30\u20138.","journal-title":"Clin Transl Radiat Oncol"},{"key":"1637_CR34","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/S0360-3016(96)00433-6","volume":"36","author":"W Rhomberg","year":"1996","unstructured":"Rhomberg W, Hassenstein EO, Gefeller D. Radiotherapy vs. radiotherapy and razoxane in the treatment of soft tissue sarcomas: final results of a randomized study. Int J Radiat Oncol Biol Phys. 1996;36:1077\u201384.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1637_CR35","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1080\/0284186X.2022.2066983","volume":"61","author":"B Allignet","year":"2022","unstructured":"Allignet B, Sunyach MP, Geets X, et al. Is there a place for definitive radiotherapy in the treatment of unresectable soft-tissue sarcoma? A systematic review. Acta Oncol. 2022;61:720\u20139.","journal-title":"Acta Oncol"},{"key":"1637_CR36","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.ijrobp.2007.04.034","volume":"69","author":"DC Weber","year":"2007","unstructured":"Weber DC, Rutz HP, Bolsi A, et al. Spot scanning proton therapy in the curative treatment of adult patients with sarcoma: the Paul Scherrer institute experience. Int J Radiat Oncol Biol Phys. 2007;69:865\u201371.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1637_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14338\/IJPT-21-00037.1","volume":"9","author":"BS Laughlin","year":"2022","unstructured":"Laughlin BS, Golafshar MA, Ahmed S, et al. Early experience using Proton Beam Therapy for Extremity Soft tissue sarcoma: a Multicenter Study. Int J Part Ther. 2022;9:1\u201311.","journal-title":"Int J Part Ther"},{"key":"1637_CR38","doi-asserted-by":"publisher","first-page":"e474","DOI":"10.1016\/j.ijrobp.2024.07.1055","volume":"120","author":"K Nakajima","year":"2024","unstructured":"Nakajima K, Sudo S, Ogino H, et al. Image-guided Proton Therapy for unresectable trunk soft-tissue sarcoma. Int J Radiat Oncol Biol Phys. 2024;120:e474\u20135.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1637_CR39","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1080\/0284186X.2023.2209267","volume":"62","author":"BS Laughlin","year":"2023","unstructured":"Laughlin BS, Golafshar M, Prince M, et al. Dosimetric comparison between proton beam therapy, intensity modulated radiation therapy, and 3D conformal therapy for soft tissue extremity sarcoma. Acta Oncol. 2023;62:473\u20139.","journal-title":"Acta Oncol"},{"key":"1637_CR40","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.ijrobp.2008.12.006","volume":"75","author":"CI Dickie","year":"2009","unstructured":"Dickie CI, Parent AL, Griffin AM, et al. Bone fractures following external beam radiotherapy and limb-preservation surgery for lower extremity soft tissue sarcoma: relationship to irradiated bone length, volume, tumor location and dose. Int J Radiat Oncol Biol Phys. 2009;75:1119\u201324.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1637_CR41","doi-asserted-by":"crossref","unstructured":"Ahmed SK, Keole SR. Proton Therapy in the adolescent and Young Adult Population. Cancers (Basel) 15, 2023.","DOI":"10.3390\/cancers15174269"},{"key":"1637_CR42","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/S1470-2045(20)30446-0","volume":"21","author":"S Bonvalot","year":"2020","unstructured":"Bonvalot S, Gronchi A, Le Pechoux C, et al. Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 2020;21:1366\u201377.","journal-title":"Lancet Oncol"},{"key":"1637_CR43","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/SLA.0000000000005492","volume":"278","author":"D Callegaro","year":"2023","unstructured":"Callegaro D, Raut CP, Ajayi T, et al. Preoperative radiotherapy in patients with primary retroperitoneal sarcoma: EORTC-62092 trial (STRASS) Versus off-trial (STREXIT) results. Ann Surg. 2023;278:127\u201334.","journal-title":"Ann Surg"},{"key":"1637_CR44","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.adro.2016.12.003","volume":"2","author":"TF DeLaney","year":"2017","unstructured":"DeLaney TF, Chen YL, Baldini EH, et al. Phase 1 trial of preoperative image guided intensity modulated proton radiation therapy with simultaneously integrated boost to the high risk margin for retroperitoneal sarcomas. Adv Radiat Oncol. 2017;2:85\u201393.","journal-title":"Adv Radiat Oncol"},{"key":"1637_CR45","doi-asserted-by":"publisher","first-page":"4308","DOI":"10.1002\/cam4.1679","volume":"7","author":"R Imai","year":"2018","unstructured":"Imai R, Kamada T, Araki N, et al. Carbon ion radiotherapy for unresectable localized axial soft tissue sarcoma. Cancer Med. 2018;7:4308\u201314.","journal-title":"Cancer Med"},{"key":"1637_CR46","doi-asserted-by":"crossref","unstructured":"Hoppe BS, Petersen IA, Wilke BK et al. Pragmatic, Prospective Comparative Effectiveness Trial of Carbon Ion Therapy, surgery, and Proton Therapy for the management of pelvic sarcomas (soft Tissue\/Bone) involving the bone: the PROSPER Study Rationale and Design. Cancers (Basel) 15, 2023.","DOI":"10.3390\/cancers15061660"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-025-01637-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11912-025-01637-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-025-01637-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T10:55:08Z","timestamp":1740480908000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11912-025-01637-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,21]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1637"],"URL":"https:\/\/doi.org\/10.1007\/s11912-025-01637-7","relation":{},"ISSN":["1523-3790","1534-6269"],"issn-type":[{"value":"1523-3790","type":"print"},{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,21]]},"assertion":[{"value":"7 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All reported studies with human subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional\/national research committee standards, and international\/national\/institutional guidelines).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}